Related Experiment Videos
Evaluation of the Genetic Systems Corp. Integra HIV-1 Pageblot system
C A Starkey1, B Yen-Lieberman, M R Proffitt
1Department of Microbiology, Cleveland Clinic Foundation, Ohio 44195.
Abstract:
The Genetic Systems Corp. Integra HIV-1 Pageblot system was evaluated as a supplementary assay to confirm the presence of antibodies to human immunodeficiency virus type 1 in 57 specimens from individuals at high risk of infection with the virus. Forty-one specimens identified as reactive in the Genetic Systems Integra HIV-1 Pageblot system were likewise identified as reactive in a U.S. Food and Drug Administration-licensed (Biotech/Dupont) Western blot (immunoblot). Six specimens identified as indeterminate in either or both immunoblot assays were all identified as nonreactive in a U.S. Food and Drug Administration-licensed enzyme immunoassay with recombinant antigens.